HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shin, H.-J. Articles by Lee, C.-W. Search for Related Content PubMed PubMed Citation Articles by Shin, H.-J. Articles by Lee, C.-W.

STAT4 Expression in Human T Cells Is Regulated by DNA Methylation but Not by Promoter Polymorphism¹

Hyun-Jin Shin^*,, Hye-Young Park, Sook-Jung Jeong, Heung-Woo Park^*, Yoon-Keun Kim^*, Sang-Heon Cho^*, You-Young Kim^*, Mi-La Cho, Ho-Youn Kim, Kyung-Up Min^* and Chang-Woo Lee^2,

^* Department of Internal Medicine, Seoul National University College of Medicine and Rheumatism Research Center, Catholic Institutes of Medical Sciences, The Catholic University of Korea, Seoul, Korea; and Research Institute, National Cancer Center, Gyeonggi, Korea

STAT4, which plays a pivotal role in Th1 immune responses, enhances IFN- transcription in response to the interaction of IL-12 with the IL-12R. Mice deficient in STAT4 lack IL-12-induced IFN- production and Th1 differentiation and display a predominantly Th2 phenotype. Although these findings indicate that STAT4 expression levels are important for the development of cytokine-producing Th1 cells, the transcriptional and posttranscriptional mechanisms regulating STAT4 expression are unknown. We sought to identify and characterize the transcriptional regulatory elements in the promoter region of the human STAT4 gene. We found that disruption of multiple transcriptional regions covering the CREB, OCT1, and SP1 motifs significantly reduced STAT4 promoter activity. However, genomic DNA isolated from 91 patients with asthma or rheumatoid arthritis showed no evidence of mutations in the defined STAT4 essential promoter region. The 5' flanking region of the promoter was found to contain a –149A/G change in 20–35% of patients, but this polymorphism had no effect on promoter activity. Interestingly, STAT4 expression was drastically increased in human T cells following treatment with a DNA methyltransferase inhibitor, and truncation of methylation sites in the proximal regulatory elements of the STAT4 promoter markedly enhanced transcriptional activity. Thus, our findings provide molecular insight into STAT4 expression and suggest that, in human T cells, STAT4 expressional regulation is associated with DNA hypermethylation, but not promoter polymorphisms.

This article has been cited by other articles:

				C. J. Gamper, A. T. Agoston, W. G. Nelson, and J. D. Powell Identification of DNA Methyltransferase 3a as a T Cell Receptor-Induced Regulator of Th1 and Th2 Differentiation J. Immunol., August 15, 2009; 183(4): 2267 - 2276. [Abstract] [Full Text] [PDF]

				S E Haberg, S J London, H Stigum, P Nafstad, and W Nystad Folic acid supplements in pregnancy and early childhood respiratory health Arch. Dis. Child., March 1, 2009; 94(3): 180 - 184. [Abstract] [Full Text] [PDF]

				M. E. Remoli, J. Ragimbeau, E. Giacomini, V. Gafa, M. Severa, R. Lande, S. Pellegrini, and E. M. Coccia NF-{kappa}B is required for STAT-4 expression during dendritic cell maturation J. Leukoc. Biol., January 1, 2007; 81(1): 355 - 363. [Abstract] [Full Text] [PDF]